Phase II Dasatinib Study in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Dasatinib
Sponsor: Duke University
Collaborators: Bristol-Myers Squibb